Prompt initiation of interferon beta-1b (BetaseronR) at the onset of suspected multiple sclerosis (MS) translates into less progression to chronic neurologic disability compared with delayed treatment, researchers announced at the 59th Annual Meeting of the American Academy of Neurology (AAN). Mark S. [click link for full article]
More...